03.12.24
L’Oréal Groupe has formally released Melasyl, its new “breakthrough” molecule designed to address localized pigmentation issues that lead to age spots and post-acne marks. L’Oréal formulations containing the new proprietary ingredient work inclusively, across all skin tones, to address pigmented marks on the skin and improve their appearance.
LaRoche-Posay is the first brand to sell a product that harnesses new ingredient, which was developed during 18 years of research, according to L'Oréal. Melasyl is the hero ingredient in LaRoche-Posay’s Mela B3 franchise, including MelaB3 serum and MelaB3 SPF30.
L’Oréal Paris and Vichy will follow with future product launches with the proprietary ingredient, according to the beauty giant
According to a worldwide epidemiological study on pigmentary disorders, half of all people report having at least one skin pigmentation issue.
Cosmetic products formulated with multi-patented Melasyl help provide a more even, natural skin tone, addressing even the most persistent marks, according to L'Oréal.
“With half of all people reporting skin pigmentation issues and a third of these experiencing lower quality of life as a result, the impact of visible spots or post-acne marks is clearly more than skin-deep,” said Anne Colonna, global head of advanced research at L’Oréal Groupe. “Melasyl is a first-of-its kind ingredient that helps to address localized skin pigmentation issues, with proven efficacy and wide accessibility that will enable more people to regain their self confidence.”
Many factors can upset normal melanin production, which can lead to localized pigmentation issues such as age spots and post-inflammatory marks. L’Oréal formulations containing Melasyl improve the appearance of existing dark spots, including persistent ones, with clinically demonstrated efficacy and safety across all skin tones.
Melasyl was first presented at the World Congress of Dermatology 2023 in Singapore, alongside the first worldwide epidemiological study on pigmentary disorders. The ingredient was featured at the recently concluded American Academy of Dermatology’s annual meeting, which was held in San Diego.
LaRoche-Posay is the first brand to sell a product that harnesses new ingredient, which was developed during 18 years of research, according to L'Oréal. Melasyl is the hero ingredient in LaRoche-Posay’s Mela B3 franchise, including MelaB3 serum and MelaB3 SPF30.
L’Oréal Paris and Vichy will follow with future product launches with the proprietary ingredient, according to the beauty giant
According to a worldwide epidemiological study on pigmentary disorders, half of all people report having at least one skin pigmentation issue.
Cosmetic products formulated with multi-patented Melasyl help provide a more even, natural skin tone, addressing even the most persistent marks, according to L'Oréal.
“With half of all people reporting skin pigmentation issues and a third of these experiencing lower quality of life as a result, the impact of visible spots or post-acne marks is clearly more than skin-deep,” said Anne Colonna, global head of advanced research at L’Oréal Groupe. “Melasyl is a first-of-its kind ingredient that helps to address localized skin pigmentation issues, with proven efficacy and wide accessibility that will enable more people to regain their self confidence.”
Many factors can upset normal melanin production, which can lead to localized pigmentation issues such as age spots and post-inflammatory marks. L’Oréal formulations containing Melasyl improve the appearance of existing dark spots, including persistent ones, with clinically demonstrated efficacy and safety across all skin tones.
Melasyl was first presented at the World Congress of Dermatology 2023 in Singapore, alongside the first worldwide epidemiological study on pigmentary disorders. The ingredient was featured at the recently concluded American Academy of Dermatology’s annual meeting, which was held in San Diego.